News That Quotes Us & Our Work Archives

FDA Advises Halt of Common Uterine Fibroid Procedure Citing Cancer Risks, Overseer Urges Stop in Use of Morcellators to Remove Uterine Growths

Wall Street Journal, April 17, 2014. The U.S. Food and Drug Administration on Thursday advised doctors to stop using power morcellators in women’s abdomens to remove uterine growths called fibroids, citing the risk of spreading cancer.

Medical Device Recalls Nearly Doubled in a Decade

Wall Street Journal, March 21, 2014. Recalls of defective medical devices nearly doubled in the decade from 2003 through 2012, according to a Food and Drug Administration report due Friday.

Study Finds Link Between Abuse Victims’ Deaths, Abuser Arrests

Milwaukee Journal Sentinel, March 3, 2014. A study released Monday that followed up on a 1980s report about mandatory domestic violence arrest policies in Milwaukee found an increased death rate among victims when suspects were arrested, rather than merely warned, by police.

Clinical Evidence in FDA Drug Approvals Varies Widely

Modern Healthcare, January 22, 2014. “With new drugs, there is often an exaggeration of the benefits and underreporting of the risks,” said Diana Zuckerman, NCHR president, who has testified at several hearings on drug safety. “There’s so much emphasis on drugs being the latest, the most innovative and novel—but unfortunately this usually means it’s just new, not necessarily better.”

BPA-Free Baby Bottles Now Law, But We’re Not in the Clear

The Huffington Post, August 14, 2012. Diana Zuckerman, NCHR President, on the substitutes being used in place of BPA: “We are very concerned that BPA could be replaced with products that are just as risky, or even more risky. The federal government is not doing what is needed to protect the American public, either in their regulation of BPA or any of these potential substitutes.”